Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Debiec-Rychter

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
Anticancer Research|April 20, 2006
Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomographyHans Prenen, Christophe Deroose, Peter Vermaelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutationsGiuseppe Floris, Raf Sciot, Agnieszka Wozniak, et al.
The International Journal of Biochemistry & Cell Biology|May 21, 2014
Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular featuresJoanna Przybyl, Raf Sciot, Agnieszka Wozniak, et al.
Oncology Research and Treatment|June 7, 2019
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral CenterCiska Langmans, Jasmien Cornillie, Thomas van Cann, et al.
Translational Oncology|May 1, 2015
Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft ModelsThomas Van Looy, Agnieszka Wozniak, Giuseppe Floris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylateHans Prenen, Jan Cools, Nicole Mentens, et al.
The Journal of Molecular Diagnostics : JMD|February 23, 2024
Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic PurposesJef Baelen, Barbara Dewaele, Maria Debiec-Rychter, et al.
Journal of Neuro-Oncology|April 5, 2003
A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her fatherEwa Izycka-Swieszewska, Maria Debiec-Rychter, Bartosz Wasag, et al.
Cancer Genetics and Cytogenetics|September 19, 2002
Molecular cytogenetic analysis of clustered sporadic and familial renal cell carcinoma-associated 3q13 approximately q22 breakpointsDaniëlle Bodmer, Irene Janssen, Yvonne Jonkers, et al.
Plos One|January 5, 2022
Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcomaJoanna Przybyl, Lien Spans, Kristen Ganjoo, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
Anticancer Research|April 20, 2006
Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomographyHans Prenen, Christophe Deroose, Peter Vermaelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutationsGiuseppe Floris, Raf Sciot, Agnieszka Wozniak, et al.
The International Journal of Biochemistry & Cell Biology|May 21, 2014
Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular featuresJoanna Przybyl, Raf Sciot, Agnieszka Wozniak, et al.
Oncology Research and Treatment|June 7, 2019
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral CenterCiska Langmans, Jasmien Cornillie, Thomas van Cann, et al.
Translational Oncology|May 1, 2015
Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft ModelsThomas Van Looy, Agnieszka Wozniak, Giuseppe Floris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylateHans Prenen, Jan Cools, Nicole Mentens, et al.
The Journal of Molecular Diagnostics : JMD|February 23, 2024
Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic PurposesJef Baelen, Barbara Dewaele, Maria Debiec-Rychter, et al.
Journal of Neuro-Oncology|April 5, 2003
A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her fatherEwa Izycka-Swieszewska, Maria Debiec-Rychter, Bartosz Wasag, et al.
Cancer Genetics and Cytogenetics|September 19, 2002
Molecular cytogenetic analysis of clustered sporadic and familial renal cell carcinoma-associated 3q13 approximately q22 breakpointsDaniëlle Bodmer, Irene Janssen, Yvonne Jonkers, et al.
Plos One|January 5, 2022
Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcomaJoanna Przybyl, Lien Spans, Kristen Ganjoo, et al.
Pageof 21